Bayer (BAYN.DE) Financial Analysis & Valuation | Quarter Chart
Bayer (BAYN.DE)
BAYN.DEPrice: $44.75
Fair Value: 🔒
🔒score
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialt... more
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. I... more
Description
Shares
| Market Cap | $43.96B | Exchange | XETRA |
| Sector | Healthcare | Industry | Drug Manufacturers - General |
| Country | DE | CEO | William N. Anderson |
| IPO Date | 1996-12-16 | CAGR | 0.02% |
| Employees | 90,587 | Website | www.bayer.com |
| Div. Yield | 0.29% | Payout Ratio | -0.06% |
| Buy Back Yield | 0.04% | Total Yield | 0.33% |
BAYN.DE chart loading...
Fundamentals
Technicals
| Enterprise Value | $71.86B | P/E Ratio | — |
| Forward P/E | 7.79 | PEG Ratio | — |
| P/S Ratio | 0.84 | P/B Ratio | 1.31 |
| P/CF Ratio | 8.36 | P/FCF Ratio | 18.79 |
| EPS | $-2.54 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | -2.87% | Gross Margin | 0.59% |
| Operating Margin | 0.15% | Profit Margin | -0.05% |
| ROE | -0.08% | ROA | -0.02% |
| ROCE | 0.09% | Current Ratio | 1.06 |
| Quick Ratio | 0.7 | Cash Ratio | 0.17 |
| Debt/Equity | 1.35 | Interest Coverage | 2.67 |
| Altman Z Score | 0.94 | Piotroski Score | 5 |